|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 366.29 USD | -1.42% |
|
+0.80% | +11.91% |
| Jul. 16 | Merck gets US FDA nod for first-in-its-class oral cholesterol drug | RE |
| Jul. 13 | BofA Securities Adjusts Amgen Price Target to $312 From $307 | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Bullish |
| Resistance | 374.15 | 388.16 | 388.16 |
| Spread/Res. | -2.10% | -5.63% | -5.63% |
| Spread/Supp. | +3.12% | +13.10% | +12.32% |
| Support | 355.2 | 323.85 | 326.1 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- AMGN Stock
- Charts Amgen Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
